SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(8 sites)

Czechia

St. Anne University Hospital, Brno

Denmark

Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark, Aarhus

Department of Cardiothoracic Surgery, Kobenhavn, Copenhagen

Odense University Hospital, Odense

Sweden

Sahlgrenska University Hospital, Gothenburg

Linköping University Hospital, Linköping

Skane University Hospital, Lund

Department of cardiology, Örebro